LI-RADS in the year 2020 – Are you already using it or still considering?

Abstract

Purpose The working group for gastrointestinal and abdominal imaging within the German Radiological Society performed a nationwide online survey in order to assess the current status regarding the awareness and application of LI-RADS, a classification for evaluation of liver lesions in patients at risk.

Materials and Methods Using the website www.deutsches-krankenhausverzeichnis.de a list of hospitals was generated meeting the criteria internal medicine, gastroenterology, general and visceral surgery and radiology (n = 391). Randomly, 102 department directors were contacted, and asked to name one consultant and one resident from their department in order to participate in the survey. 177 potential participants were invited to fill out an approximately 10-minute online survey in the form of 17 questions regarding the awareness and application of LI-RADS. The results of the survey were analyzed by means of descriptive statistics.

Results 77 participants were registered, which corresponds to a response rate of 43.5 %. 47 % of all participants were radiologists, 30 % surgeons and 23 % internal doctors/gastroenterologists, respectively, many with more than 13 years of professional experience (37.2 %). The majority of participants worked in a hospital with a focus (37.2 %) or a university hospital (29.1 %). Even though the majority of participants knows about or has heard of LI-RADS (73.2 %), only a minority uses the classification themselves (26 %) or within the context of tumor boards (19.2 %).

Conclusion The results of our survey demonstrate that LI-RADS is relatively known in Germany, the application however quite sparse. This is in contrast to the general desire and endeavor for more standardized reporting in radiology.

Key points

• LI-RADS is not yet broadly implemented in clinical routine in Germany

• The sparse application is in contrast to the general desire for more standardized reporting in radiology

• Interdisciplinary education may support the propagation and use of the LI-RDAS classification

Citation Format

• Ringe KI, Gut A, Grenacher L et al. LI-RADS in the year 2020 – Are you already using it or still considering? Fortschr Röntgenstr 2021; 193: 186 – 193

Key words

LI-RADS - liver - HCC - CT - ultrasound - MR-imaging

Publication History

Received: 12 March 2020

Accepted: 21 June 2020

Article published online:
20 July 2020

• References

• 1 American College of Radiology Liver Imaging Reporting and Data System. https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS . Zugriff am 28.02.2020
• 2 Mercado CL. BI-RADS update. Rad Clin N Am 2014; 52: 481-487
• 3 Sirlin CB. The LI-RADS adventure-a personal statement. Abdom Rad 2018; 43: 1-2
• 4 Dietrich CF, Potthoff A, Helmberger T. et al. Standardisierte Befundung und Dokumentation der Kontrastmittelsonografie der Leber (CEUS LI-RADS). Z Gastroenterol 2018; 56: 499-506
• 5 Elsayes KM, Chernyak V, Morshid AI. et al. Spectrum of Pitfalls, Pseudolesions, and Potential Misdiagnoses in Cirrhosis. Am J Roentgenol Am J Rroentgenol 2018; 211: 87-96
• 6 Santillan C, Chernyak V, Sirlin C. LI-RADS categories: concepts, definitions, and criteria. Abdom Rad 2018; 43: 101-110
• 7 Sirlin CB, Kielar AZ, Tang A. et al. LI-RADS: a glimpse into the future. Abdom Rad 2018; 43: 231-236
• 8 Marrero JA, Kulik LM, Sirlin CB. et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2018; 68: 723-750
• 9 Kielar AZ, Chernyak V, Bashir MR. et al. An update for LI-RADS: Version 2018. Why so soon after version 2017?. J Magn Reson Imaging 2019; 50: 1990-1991
• 10 Goldberg-Stein S, Walter WR, Amis Jr ES. et al. Implementing a Structured Reporting Initiative Using a Collaborative Multistep Approach. Curr Probl Diagn Radiol 2017; 46: 295-299
• 11 Elsayes KM, Kielar AZ, Elmohr MM. et al. White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI. Abdom Rad 2018; 43: 2625-2642
• 12 Pinto Dos Santos D, Hempel JM, Mildenberger P. et al. Structured Reporting in Clinical Routine. Fortschr Röntgenstr 2019; 191: 33-39
• 13 Pinto Dos Santos D, Arnhold G, Mildenberger P. et al. Guidelines Regarding section sign16 of the German Transplantation Act – Initial Experiences with Structured Reporting. Fortschr Röntgenstr 2017; 189: 1145-1151
• 14 Herden U, Schoening W, Pratschke J. et al. Accuracy of Pretransplant Imaging Diagnostic for Hepatocellular Carcinoma: A Retrospective German Multicenter Study. Can J Gastroenterol Hepatol 2019; 2019: 8747438
• 15 Goldberg DTS, Maly T, Aldrich W. 2015 htpps://www.surveymokey.com
• 16 Renzulli M, Clemente A, Brocchi S. et al. LI-RADS: a great opportunity not to be missed. Eur J Gastroenterol Hepatol 2019; 31: 283-288
• 17 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 2018; 69: 182-236
• 18 Kambadakone AR, Fung A, Gupta RT. et al. LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound. Abdom Rad 2018; 43: 56-74
• 19 Greten TF, Malek NP, Schmidt S. et al. Diagnostik und Therapie die hepatozellulären Karzinoms. Z Gastroenterol 2013; 51: 1269-1326
• 20 Siedlikowski ST, Kielar AZ, Ormsby EL. et al. Implementation of LI-RADS into a radiological practice. Abdom Rad 2018; 43: 179-184
• 21 Der Duden. www.duden.de . Zugriff am 28.08.2020
• 22 Choi SH, Lee SS, Park SH. et al. LI-RADS classification and prognosis of primary liver cancers at gadoxetic acid-enhanced MRI. Radiology 2019; 290: 388-397
• 23 Flusberg M, Ganeles J, Ekinci T. et al. Impact of a Structured Report Template on the Quality of CT and MRI Reports for Hepatocellular Carcinoma Diagnosis. J Am Coll Rad 2017; 14: 1206-1211